Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arianna Brevi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cellular & Molecular Immunology|July 18, 2017
Fatty is not that bad: feeding short-chain fatty acids to restrain autoimmunityArianna Brevi, Matteo Bellone
Cancer Research|June 15, 2023
Live Biotherapeutic Products as Cancer TreatmentsArianna Brevi, Amir Zarrinpar
Microbiology and Molecular Biology Reviews : MMBR|March 6, 2020
Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and CancerMatteo Bellone, Arianna Brevi, Samuel Huber
Frontiers in Immunology|April 4, 2022
The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple MyelomaArianna Brevi, Laura Lucia Cogrossi, Marco Lorenzoni, et al.
Annals of Biomedical Engineering|June 15, 2026
Bile Salts and Bacterial Bile Salt Hydrolase Activity Influence Escherichia coli Colonization and FXR Signaling in Colorectal Cancer OrganoidsIshita Dasgupta, Arianna Brevi, Yixiao Ma, et al.
Frontiers in Immunology|November 27, 2020
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and CancerArianna Brevi, Laura Lucia Cogrossi, Giulia Grazia, et al.
Trends in Cancer|May 1, 2024
Engineered bacterial therapeutics for detecting and treating CRCNicole Siguenza, Arianna Brevi, Joanna T Zhang, et al.
Cancer Immunology, Immunotherapy : CII|January 16, 2022
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020Matteo Bellone, Arianna Brevi, Vincenzo Bronte, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2023
Cancer immunity and immunotherapy beyond COVID-19Matteo Bellone, Arianna Brevi, Vincenzo Bronte, et al.
Blood Advances|July 16, 2021
CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanismMatteo Grioni, Arianna Brevi, Elena Cattaneo, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cellular & Molecular Immunology|July 18, 2017
Fatty is not that bad: feeding short-chain fatty acids to restrain autoimmunityArianna Brevi, Matteo Bellone
Cancer Research|June 15, 2023
Live Biotherapeutic Products as Cancer TreatmentsArianna Brevi, Amir Zarrinpar
Microbiology and Molecular Biology Reviews : MMBR|March 6, 2020
Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and CancerMatteo Bellone, Arianna Brevi, Samuel Huber
Frontiers in Immunology|April 4, 2022
The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple MyelomaArianna Brevi, Laura Lucia Cogrossi, Marco Lorenzoni, et al.
Annals of Biomedical Engineering|June 15, 2026
Bile Salts and Bacterial Bile Salt Hydrolase Activity Influence Escherichia coli Colonization and FXR Signaling in Colorectal Cancer OrganoidsIshita Dasgupta, Arianna Brevi, Yixiao Ma, et al.
Frontiers in Immunology|November 27, 2020
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and CancerArianna Brevi, Laura Lucia Cogrossi, Giulia Grazia, et al.
Trends in Cancer|May 1, 2024
Engineered bacterial therapeutics for detecting and treating CRCNicole Siguenza, Arianna Brevi, Joanna T Zhang, et al.
Cancer Immunology, Immunotherapy : CII|January 16, 2022
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020Matteo Bellone, Arianna Brevi, Vincenzo Bronte, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2023
Cancer immunity and immunotherapy beyond COVID-19Matteo Bellone, Arianna Brevi, Vincenzo Bronte, et al.
Blood Advances|July 16, 2021
CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanismMatteo Grioni, Arianna Brevi, Elena Cattaneo, et al.
Pageof 2